Logipharma 2018

April 10-April 12, 2018

Montreux Music & Convention Centre, Switzerland

44 (0) 20 7368 9854

Whitepapers & Reports

The Supply Chain of the Future

From rapid shifts in supply and demand, to impending regulatory changes, disruptive technologies and, of course, the need to maintain supply chain integrity, there are plenty of stress-factors to be aware of – and solutions to be found.
In advance of LogiPharma 2017, we interviewed 100 senior decision makers in the industry to investigate some of the issues which are driving transformation in the pharmaceutical supply chain today.

Key Strategies for Global Trade Management in the Life Sciences Industry

WGB_60025
Click the image to the left to download your copy!

Covering the best practices gathered in KPIT's global trade compliance roundtable session at PharmaForce 2016, this report will show you the challenges your peers are encountering, as well as how they are optimizing their global logistics strategies.


Soothing Your Supply Chain Headaches

In a competitive global economy, a supply chain which contributes meaningfully to the bottom line will effectively differentiate your company from the competition.
 
Inside you will discover
  • The biggest challenges facing pharma supply chain executives and how this has changed in a year
  • Industry readiness for the EU Falsified Medicines Directive 
  • How many companies are using KPIs to monitor performance of suppliers

Attendee List

Thinking about attending LogiPharma Europe? Want to know who else is confirmed to attend?
 
Let me tell you, you’ll be impressed with who we have attending so far. This year’s event will be sure to cover your biggest pharma supply chain challenges so don’t miss out.

Fill out the short form below to download the latest list of attendees


Achieving 360 Degree Pharmaceutical Supply Chain Visibility

In the first quarter of 2017, BSI and LogiPharma partnered to research how global pharmaceutical executives are identifying and mitigating global threats to their supply chains. What global markets are currently being looked at for the sourcing of active pharmaceutical ingredients, as well as excipients? What tools and strategies are being adopted for the development of heightened visibility over each point of articulation within the supply chain? What are the current significant risk factors that jeopardize the security and continuity of pharmaceutical products quality, life cycle management and logistics? This report seeks to illuminate the answers to these questions through analyzing the anonymous responses of 73 executive members of the LogiPharma event community.